New AI Tools Aim to Identify Tissue Samples at Risk of Failed Molecular Testing
Aignostics has launched HETA Clinical, an AI suite for assessing H&E slide quality and tumor content. It aims to reduce failed molecular tests.
Read the original →Article digest · Oct 19 AM
AI in Medicine — what each story says
Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
13 stories7 with summaries8 topics
🩻 Diagnosis and imaging4
- Headlines only (the publisher did not provide a description)
- Judge AI in health care by its worst answer, not its bestKevinMD.com · 10/18 15:07 UTC
- OxyContin maker Purdue Pharma set to dissolve after $5B sentence; Mayo Clinic AI detects pancreatic cancer years before diagnosis; results of FDA’s largest-ever infant formula test – Morning Medical UpdateMedical Economics · 10/17 17:40 UTC
- AI Reads Hidden Brain Injury in Newborns When MRI Looks Normalbioengineer.org · 10/17 22:51 UTC
🩺 Clinical decision support1
The Hidden Bias in AI Healthcare May Come From Clinicians, Not Algorithms
A new perspective in the Journal of General Internal Medicine argues that clinicians' discretionary use of AI can reproduce or amplify inequities. It also argues that human-in-the-loop oversight offers only limited protection.
Read the original →📝 Generative AI, documentation and records1
AI Will Accelerate Inflation Because It Cannot Deliver Value In Today's Health Care Market
David Brailer replies to responses from Jonathan Ketcham and Ken Terry to his original article. He writes about a market built around volume rather than value.
Read the original →🏥 Hospital operations and care delivery1
- Headlines only (the publisher did not provide a description)
- Health Ministry adopts AI for early detectionPressReader · 10/17 06:39 UTC
💊 Drug discovery and clinical trials3
Drug Discovery Informatics Market To 2035: AI Integration and R&D Efficiency Drive Growth
The global drug discovery informatics market is set to expand through 2035. Growth is supported by AI adoption and the need to improve pharmaceutical R&D productivity.
Read the original →Dodo revival: Colossal Biosciences uses AI to identify genetic targets
Colossal Biosciences uses AI to identify genetic targets for dodo revival. It is also studying the Nicobar pigeon and conservation needs in Mauritius.
Read the original →- Headlines only (the publisher did not provide a description)
- Tempus AI, Inc. (TEM) Stock Price, News, Quote & HistoryYahoo! Finance Canada · 10/17 18:43 UTC
⚖️ Device approvals and regulation1
MRI2CT Secures FDA Clearance for AI Spine Imaging Platform
MRI2CT Inc. has received U.S. Food and Drug Administration 510(k) clearance for an artificial intelligence imaging platform. The platform generates three-dimensional bone images of the lower spine.
Read the original →🔬 Research results (major journals)1
- Headlines only (the publisher did not provide a description)
- AI predicts who will win The Celebrity TraitorsLADbible · 10/18 11:34 UTC
🇯🇵 Medicine and AI in Japan1
AI helps predict breast cancer recurrence risk early
A new AI tool approved by the US Food and Drug Administration can assess the risk of breast cancer recurrence within 5 to 10 years. It helps doctors and patients make informed choices about appropriate treatment.
Read the original →The analysis and visual summary are in the Oct 19 AM issue. Japanese version here.